- Home
- ACXP vs GLMD Comparison
ACXP vs GLMD Comparison
Compare ACXP & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- GLMD
- Stock Information
- Founded
- ACXP 2017
- GLMD 2000
- Country
- ACXP United States
- GLMD Israel
- Employees
- ACXP N/A
- GLMD N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- ACXP Health Care
- GLMD Health Care
- Exchange
- ACXP Nasdaq
- GLMD Nasdaq
- Market Cap
- ACXP 9.1M
- GLMD 7.9M
- IPO Year
- ACXP 2021
- GLMD 2014
- Fundamental
- Price
- ACXP $4.70
- GLMD $1.49
- Analyst Decision
- ACXP Strong Buy
- GLMD Hold
- Analyst Count
- ACXP 3
- GLMD 1
- Target Price
- ACXP $143.67
- GLMD N/A
- AVG Volume (30 Days)
- ACXP 66.2K
- GLMD 164.0K
- Earning Date
- ACXP 08-12-2025
- GLMD 09-02-2025
- Dividend Yield
- ACXP N/A
- GLMD N/A
- EPS Growth
- ACXP N/A
- GLMD N/A
- EPS
- ACXP N/A
- GLMD N/A
- Revenue
- ACXP N/A
- GLMD N/A
- Revenue This Year
- ACXP N/A
- GLMD N/A
- Revenue Next Year
- ACXP N/A
- GLMD N/A
- P/E Ratio
- ACXP N/A
- GLMD N/A
- Revenue Growth
- ACXP N/A
- GLMD N/A
- 52 Week Low
- ACXP $3.80
- GLMD $1.15
- 52 Week High
- ACXP $47.80
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- ACXP 33.75
- GLMD 44.36
- Support Level
- ACXP $4.40
- GLMD $1.35
- Resistance Level
- ACXP $5.29
- GLMD $1.59
- Average True Range (ATR)
- ACXP 0.51
- GLMD 0.11
- MACD
- ACXP 0.08
- GLMD 0.00
- Stochastic Oscillator
- ACXP 40.91
- GLMD 44.56
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.